3. Founded in 2000, by Mr. Arvind Sheth, a veteran in the
Pharmaceutical industry, who has over four decades of experience
Deals with manufacturing and sale of APIs, intermediates and
formulations
Operate in every level of pharma operations from sourcing to
sale/registering
Also deals in exporting and in licensing
Has built itself into a leading supplier of requirements of all sectors
of pharmaceutical and chemical industry in India
4. Commenced in 2004
Primarily focused with contract manufacturing of over 1,000
finished formulations, for top 20 Indian companies
Over 4 years of successful in licensing activities
Local and Global Principals create strong business network
Also aid in in-licensing
market
global pharma products in Indian
6. P2P business model
Contract Manufacturing/ Loan Licensing
Loan licensed with 15 manufacturing units across India
Sourcing of API and intermediates from Orbit Impex (SBU of
Orbit Group), therefore more reliable and cheaper
WHO GMP, MHRA and USFDA approved Manufacturing units
7. Client Orders
Idenitify required APIs
Manufacture/Source API
• Customers include top pharma businesses
• API and intermediates required for the manufacturing of the formulations
are traced
(or from Orbit Impex)
• Lifescience gets the APIs, mostly from their own sister business unit,
reducing costs and increasing efficiency
• Factory in Hyderabad, manufactures API
Contract Manufacture
Formulation
• Lifescience owns/loan license manufacturing units and provide materials
and technologies and contracts out to these WHO GMP approved
manufacturers
Deliver Order
8. Our own WHO GMP certified manufacturing
unit devoted to manufacturing APIs and
formulations to our demand, in Hyderabad
Through loan licensing/ stakes in factories,
gives us a competitive edge over competitors
Benefit from quick, efficient and quality
materials and APIs at our disposal to meet
order requirements
11. Research and find novel formulations, pharma
goods or concepts through extensive research
Using extensive network and relations to establish
new product in local and overseas market
Benefit from ‘first-mover’ advantage and rigorous
overseas contacts
12. Research team finds novel
products
• Expert research team scouts for novel/ patented formulations of
pharma goods developed around the world (E.g. USA, Europe, Israel)
Buy patent/ license of novel
product
• Arrange for a license/patent with developers (of WHO GMP and
regulatory market approved plants)
Bring product into the Indian
Pharma Market
• Through technology transfer, ready-to fill bulk or API/finished
formulations delivery
Market product
• Through networks sub-license to leading market companies or
market novel product by ourselves
Widen sales to overseas
markets through existing/new
business links
13. “V-wash’, female intimate hygiene
product
In licensed from CTS Israel
CTS Israel leading company in respective
industry
Lifescience licensed to Glenmark
Glenmark successfully introduced
product into Indian market, fruition into
approx. $ 2million brand in 3 years
14. ‘Visnadin’ (Evarise), a highly recommended gel
treatment for female sexual arousal disorder
Orbit Lifescience holds patent and marketing
rights for this formulation in over 140 countries
In licensed from Europe, and commercialized
under cosmetics in Nordic, Scandinavian countries
and USA
Sub licensed for sale in India, MENA and SouthEast Asia, to leading market companies
15. Lifescience has successfully registered pharma
products from its counterparts in China into
Indian market
Our experience and relations make us a
perfect aid to International brands to enter
Indian market
Orbit covers entire chain of process in pharma
industry and thus well equipped
16. Experienced research team
Strong local and global business links
Relations with Pharma market’s leading
companies
Streamlined structure makes process
quick and efficient
17. Growth since inception in
2004
Above market average
growth
In Licensing
70
Manufacturing
60
50
Percentage
Growth 40
Sales(%)
30
Successfully in licensed
few products within 2
years span
20
Increase in sales and
venturing into exports
0
10
2009
2010
2011
2012
Graph showing percentage increase in
sales with base year 2008
18. Increase exports to foreign pharma markets
In licensing niche patented products in Indian as well
as global market
In the search for innovative and novel formulations
to better the healthcare system
Help introduce these into the Indian market with the
aid of our strong and experienced business links
19. Head Office, Mumbai:
13, Kailash Darshan 4th Floor
Nana Chowk 400007, Mumbai
Tel: +91-022-23803200
Fax: +91-022-23803202
For further details please visit www.orbitlifescience.com
